Latest Regulatory Approval News

Asara Resources has agreed to acquire two adjacent gold exploration permits in Guinea, significantly enlarging its Kada Gold Project footprint in the prolific Siguiri Basin. Historical drilling by Newmont highlights promising gold mineralisation, setting the stage for renewed exploration.

Almonty Industries has announced a $15 million public offering of common shares in the US, aiming to accelerate development across its tungsten and molybdenum projects amid rising global demand.

Beacon Minerals reports strong assay results from its ongoing drill program at the Iguana Deposit, alongside securing vital land use and mining approvals, advancing the Lady Ida Project towards production.

L1 Global Long Short Fund Limited (ASX – GLS) has opened a pro-rata non-renounceable entitlement offer to raise up to A$415 million, marking a pivotal step in its transition to L1 Capital’s Global Long Short Strategy. The offer includes a Top-Up Facility and a subsequent institutional placement to meet strong investor demand.

Immutep has struck a strategic licensing deal with Dr. Reddy’s, granting rights to commercialise its novel cancer immunotherapy Eftilagimod Alfa across key emerging markets. The agreement includes a $20 million upfront payment and potential milestones exceeding $349 million.

Canyon Resources confirms steady progress on its Minim Martap Bauxite Project in Cameroon, with mining set to start in early 2026 and the first bauxite shipment planned for June. Key infrastructure and equipment deliveries remain on schedule amid ongoing equity funding efforts.

Antares Metals (ASX – AM5) announces the acquisition of full interests in two promising Western Australian gold and copper-zinc projects, backed by a $2 million capital raise to fund exploration and drilling in early 2026.

Memphasys is intensifying its direct sales efforts for the Felix™ sperm-selection device across key Middle East IVF clinics, positioning for rapid market activation upon CE Mark approval expected early 2026.

Meteoric Resources is poised for a critical environmental milestone as the Preliminary Environmental Licence for its Caldeira Rare Earth Project is set for approval at the upcoming COPAM meeting. This step could unlock the path to construction and keep the project timeline intact.

Imugene Limited has received positive feedback from the FDA, aligning key requirements to progress its azer-cel therapy into a pivotal clinical trial, underscoring its growing promise in blood cancer treatment.

National Storage REIT has entered a definitive agreement to be acquired by a Brookfield and GIC-led consortium for $2.86 per security, valuing the company at $4 billion. The Board unanimously recommends the scheme, pending shareholder and regulatory approvals.

Chalice Mining’s Pre-Feasibility Study confirms the Gonneville Project as a globally significant palladium-nickel-copper mine in Western Australia, boasting robust returns and a rapid payback period.